Google AI Can Now More Accurately Sequence Your Genome
It seems that we see almost daily news stories about artificial intelligence (AI) and innovations that are being realized as the result of this technology. While terms like "groundbreaking" are typically the result of hype and hyperbole, the developments in the area of deep learning are certainly worthy of the term.
Researchers at Verily, the life sciences division of Alphabet Inc. (NASDAQ: GOOGL) (NASDAQ: GOOG), in collaboration with the Google Brain team, another subsidiary which leads the company's pioneering AI efforts, have applied deep learning to the solving of the human genome, with encouraging results. In a research blog published last week, the scientists announced the release of a new open-source AI system called DeepVariant, which is capable of assembling a more complete rendering of the human genome.
Google is using AI to provide a more accurate picture for genetic sequencing. Image source: Getty Images.
Source: Fool.com
Alphabet Inc. A Stock
The stock is an absolute favorite of our community with 95 Buy predictions and no Sell predictions.
As a result the target price of 177 € shows a slightly positive potential of 14.8% compared to the current price of 154.18 € for Alphabet Inc. A.
